Please wait while the formulary information is being retrieved.
XOPENEX (LEVALBUTEROL HCL)
- Bronchospastic pulmonary disease
- Acute asthma attack
- Bronchospasm prevention
- Xopenex Solution For Nebulization
- Levalbuterol Solution For Nebulization
- Levalbuterol Neb Solution
- By Indication
0.31 mg/3 mL solution for nebulization
- Dosage information is not available
0.63 mg/3 mL solution for nebulization
- Inhale 3 milliliters (0.63 mg) by nebulization route every 8 hours
1.25 mg/3 mL solution for nebulization
- Inhale 3 milliliters (1.25 mg) by nebulization route every 8 hours
levalbuterol 0.31 mg/3 mL solution for nebulization
- Dosage information is not available
levalbuterol 0.63 mg/3 mL solution for nebulization
- Inhale 3 milliliters (0.63 mg) by nebulization route every 8 hours
levalbuterol 1.25 mg/3 mL solution for nebulization
- Inhale 3 milliliters (1.25 mg) by nebulization route every 8 hours
levalbuterol concentrate 1.25 mg/0.5 mL solution for nebulization
- Inhale 0.5 milliliter (1.25 mg) by inhalation route 3 times per day via nebulizer
levalbuterol 0.31 mg/3 mL solution for nebulization
- Dosage information is not available
levalbuterol 0.63 mg/3 mL solution for nebulization
- Inhale 3 milliliters (0.63 mg) by nebulization route every 8 hours
levalbuterol 1.25 mg/3 mL solution for nebulization
- Inhale 3 milliliters (1.25 mg) by nebulization route every 8 hours
levalbuterol concentrate 1.25 mg/0.5 mL solution for nebulization
- Inhale 0.5 milliliter (1.25 mg) by inhalation route 3 times per day via nebulizer
Acute asthma attack
- Inhale 3 milliliters (0.63 mg) by nebulization route every 8 hours
- Inhale 3 milliliters (1.25 mg) by nebulization route 3 times per day
- Inhale 3 milliliters (1.25 mg) by nebulization route every 8 hours
Bronchospasm prevention
- Inhale 3 milliliters (0.63 mg) by nebulization route 3 times per day
- Inhale 3 milliliters (0.63 mg) by nebulization route every 8 hours
- Inhale 3 milliliters (1.25 mg) by nebulization route 3 times per day
- Inhale 3 milliliters (1.25 mg) by nebulization route every 8 hours
- Inhale 3 milliliters (1.25 mg) by nebulization route every 6 hours
Bronchospastic pulmonary disease
- Inhale 3 milliliters (0.63 mg) by nebulization route 3 times per day
- Inhale 3 milliliters (0.63 mg) by nebulization route every 8 hours
- Inhale 3 milliliters (1.25 mg) by nebulization route 3 times per day
- Inhale 3 milliliters (1.25 mg) by nebulization route every 8 hours
- Inhale 3 milliliters (1.25 mg) by nebulization route every 6 hours
- None
Contraindicated
- bromocriptine
- cabergoline
- Cafergot
- Compound 347
- Cycloset
- D.h.e.45
- dihydroergotamine
- enflurane
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- Forane
- isoflurane
- methylergonovine
- Migergot
- Migranal
- Parlodel
- sevoflurane
- Sojourn
- Terrell
- Ultane
Severe
Moderate
- None
- None
Contraindicated
- Congenital long QT syndrome
- Hypokalemia
- Prolonged QT interval
Severe
Moderate
- Cardiac arrhythmia
- Chronic myocardial ischemia
- Diabetes mellitus
- Hypertension
- Hyperthyroidism
- Ketoacidosis
- Kidney disease with reduction in GFR
- Metabolic acidosis
- Seizure disorder
XOPENEX (LEVALBUTEROL HCL)
- Bronchospastic pulmonary disease
- Acute asthma attack
- Bronchospasm prevention
- Tachycardia
- Cough
- Cramps in legs
- Dizziness
- Dyspepsia
- Flu-like symptoms
- Headache disorder
- Hypertonia
- Migraine
- Nervousness
- Rhinitis
- Sinusitis
- Symptoms of anxiety
- Tremor
- Viral infection
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Angioedema
- Asthma exacerbation
- Cardiac arrhythmia
- Chest pain
- Chest tightness
- Dyspnea
- Hypertension
- Hypotension
- Metabolic acidosis
- Paradoxical bronchospasm
- Pharyngeal edema
- Syncope
- Urticaria
- Wheezing
Less Severe
- Diarrhea
- Disorder of the digestive system
- Dry throat
- Hypesthesia
- Insomnia
- Lymphadenopathy
- Myalgias
- Nausea
- Ocular itching
- Paresthesia
- Skin rash
- Vomiting
- Xerostomia
Contraindicated
None
Severe Precaution
Levalbuterol (Inh_Solution)
Increased risk of worsening asthma or pulmonary function age < 6 years. Not indicated age < 6 years.
- 1 Day – 6 Years
- Increased risk of worsening asthma or pulmonary function age < 6 years. Not indicated age < 6 years.
Management or Monitoring Precaution
None
Levalbuterol
- Severity Level:
2
- Additional Notes: Insufficient human data
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Levalbuterol
Plasma levels very low in humans; mfr recommends caution
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Plasma levels very low in humans; mfr recommends caution |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Acute asthma attack | |
| J45.21 | Mild intermittent asthma with (acute) exacerbation |
| J45.22 | Mild intermittent asthma with status asthmaticus |
| J45.31 | Mild persistent asthma with (acute) exacerbation |
| J45.32 | Mild persistent asthma with status asthmaticus |
| J45.41 | Moderate persistent asthma with (acute) exacerbation |
| J45.42 | Moderate persistent asthma with status asthmaticus |
| J45.51 | Severe persistent asthma with (acute) exacerbation |
| J45.52 | Severe persistent asthma with status asthmaticus |
| J45.901 | Unspecified asthma with (acute) exacerbation |
| J45.902 | Unspecified asthma with status asthmaticus |
| J98.01 | Acute bronchospasm |
| Bronchospasm prevention | |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.909 | Unspecified asthma, uncomplicated |
| J45.990 | Exercise induced bronchospasm |
| J45.998 | Other asthma |
| Bronchospastic pulmonary disease | |
| J44.1 | Chronic obstructive pulmonary disease with (acute) exacerbation |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J45 | Asthma |
| J45.2 | Mild intermittent asthma |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.21 | Mild intermittent asthma with (acute) exacerbation |
| J45.22 | Mild intermittent asthma with status asthmaticus |
| J45.3 | Mild persistent asthma |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.31 | Mild persistent asthma with (acute) exacerbation |
| J45.32 | Mild persistent asthma with status asthmaticus |
| J45.4 | Moderate persistent asthma |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.41 | Moderate persistent asthma with (acute) exacerbation |
| J45.42 | Moderate persistent asthma with status asthmaticus |
| J45.5 | Severe persistent asthma |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.51 | Severe persistent asthma with (acute) exacerbation |
| J45.52 | Severe persistent asthma with status asthmaticus |
| J45.9 | Other and unspecified asthma |
| J45.90 | Unspecified asthma |
| J45.901 | Unspecified asthma with (acute) exacerbation |
| J45.902 | Unspecified asthma with status asthmaticus |
| J45.909 | Unspecified asthma, uncomplicated |
| J45.99 | Other asthma |
| J45.990 | Exercise induced bronchospasm |
| J45.998 | Other asthma |
| 0-9 | A-Z |
|---|---|
| J44.1 | Chronic obstructive pulmonary disease with (acute) exacerbation |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J45 | Asthma |
| J45.2 | Mild intermittent asthma |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.21 | Mild intermittent asthma with (acute) exacerbation |
| J45.21 | Mild intermittent asthma with (acute) exacerbation |
| J45.22 | Mild intermittent asthma with status asthmaticus |
| J45.22 | Mild intermittent asthma with status asthmaticus |
| J45.3 | Mild persistent asthma |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.31 | Mild persistent asthma with (acute) exacerbation |
| J45.31 | Mild persistent asthma with (acute) exacerbation |
| J45.32 | Mild persistent asthma with status asthmaticus |
| J45.32 | Mild persistent asthma with status asthmaticus |
| J45.4 | Moderate persistent asthma |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.41 | Moderate persistent asthma with (acute) exacerbation |
| J45.41 | Moderate persistent asthma with (acute) exacerbation |
| J45.42 | Moderate persistent asthma with status asthmaticus |
| J45.42 | Moderate persistent asthma with status asthmaticus |
| J45.5 | Severe persistent asthma |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.51 | Severe persistent asthma with (acute) exacerbation |
| J45.51 | Severe persistent asthma with (acute) exacerbation |
| J45.52 | Severe persistent asthma with status asthmaticus |
| J45.52 | Severe persistent asthma with status asthmaticus |
| J45.9 | Other and unspecified asthma |
| J45.90 | Unspecified asthma |
| J45.901 | Unspecified asthma with (acute) exacerbation |
| J45.901 | Unspecified asthma with (acute) exacerbation |
| J45.902 | Unspecified asthma with status asthmaticus |
| J45.902 | Unspecified asthma with status asthmaticus |
| J45.909 | Unspecified asthma, uncomplicated |
| J45.909 | Unspecified asthma, uncomplicated |
| J45.99 | Other asthma |
| J45.990 | Exercise induced bronchospasm |
| J45.990 | Exercise induced bronchospasm |
| J45.998 | Other asthma |
| J45.998 | Other asthma |
| J98.01 | Acute bronchospasm |
Formulary Reference Tool